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ABSTRACT
Objective: Selenoprotein-S (SELS) is involved in the
stress response within the endoplasmic reticulum (ER)
and inflammation. Recently, promoter variants in the SELS
gene were shown to be associated with plasma levels of
interleukin (IL)6, IL1b and tumour necrosis factor (TNF). It
was hypothesised that these variants could influence
rheumatoid arthritis (RA) susceptibility and may interact
with functional single nucleotide polymorphisms (SNPs) in
the genes for IL1, IL6 and TNF.
Methods: Genotyping was performed in 988 unrelated
healthy controls and 965 patients with RA. Stratified
analysis was used to test for interactions. Single gene
effects and evidence of epistasis were investigated using
the Mantel–Haenszel (M–H) test and the linkage
disequilibrium (LD)-based statistic.
Results: No association of SELS 2105 genotype and RA
susceptibility was detected. Stratification of SELS 2105
genotypes by IL1 2511 genotypes showed that the
disease risk (comparing AA/GA to GG at the SELS 2105
locus) in individuals with the GG/AG genotype at the IL1b
2511 locus was significantly lower than that in
individuals having the AA genotype at the IL1b 2511
locus (odds ratio (OR): 0.9 and 2.3, respectively;
p = 0.004 by M–H test). Significant epistasis was also
detected using the LD-based statistic (p =,0.001). No
interaction was observed between SELS 2105 and IL6 or
TNF variants.
Conclusion: Our results reveal evidence of strong
epistasis in two genes in the IL1 production pathway and
highlight the potential importance of gene–gene interac-
tions in the pathogenesis of RA.
Rheumatoid arthritis (RA) is an autoimmune
disease with a prevalence of 1%. The contribution
of genetic factors on RA susceptibility is shown by
twin and population studies. The concordance
rates on monozygotic twins ranges from 12% to
15% while in dizygotic twins it is 3% to 4%.1 The
major genetic component influencing RA suscept-
ibility is a group of alleles in the DRB1 gene sharing
a sequence motif, namely the ‘‘shared epitope’’
(SE). Recent evidence has also implicated the
common allele of the R620W variant in the
haematopoietic-specific protein tyrosine kinase
protein tyrosine phosphatase non-receptor type
22 (PTPN22) with susceptibility to several auto-
immune diseases including RA.2 The recent gen-
ome-wide association study conducted by the
Wellcome Trust Case Control Consortium
(WTCCC) screened 1860 RA cases and 2938
healthy controls strongly replicated the association
of the PTPN22 with RA susceptibility (p,0.001).3
Nine additional new loci of particular interest were
also identified with significant (,0.001) p values,
such as variants close to the a and b chains of the
IL2R as well as genes involved in the tumour
necrosis factor (TNF) pathway and T cell regula-
tion.3 A replication study of these 9 loci was also
performed in an independent cohort of 5063 RA
cases and 3849 healthy controls collected from 6
different centres and confirmed the association of
rs6920220, located on 6q23 between OLIG3 and
TNFAIP3, with increased risk of anti-cyclic citrul-
linated peptide (CCP)-positive RA as well as the
nominal association of the IL2RB gene.4 TNF
receptor-associated factor 1 (TRAF1) and comple-
ment component 5 (C5) loci have also emerged as
candidate regions by a genome-wide association
study and a candidate gene approach study.5 6
The identification of RA susceptibility genes is
complicated by a number of factors including
genetic and disease heterogeneity, gene–gene and
gene–environment interactions. Epistasis is defined
as a gene–gene interaction in which the genotype
at one locus affects the phenotypic expression of
the genotype at another locus. A gene with a weak
effect on overall disease risk may be important in
combination with other genes. Although the
extent of epistasis in autoimmune diseases is still
unclear, it is reasonable to postulate that such
interactions may be a consequence of functional
polymorphisms in genes involved in pathways that
are implicated in the disease process.
In RA, evidence of interactions comes from
linkage and association studies. The first European
genome scan provided evidence of RA linkage on
chromosome 3 that was stronger in human
leukocyte antigen (HLA)-identical sibpairs, sug-
gesting possible interactions between the HLA-
DRB1 locus and a region on chromosome 3.7 The
second European genome scan demonstrated RA
linkage to the interleukin 1 (IL1) locus that was
restricted to HLA-identical sibpairs suggesting that
genes of the IL1 cluster may play an additional role
only in the presence of RA-related HLA alleles.8
More recently a gene interaction was detected
between PTPN22 R620W and HLA-DRB1 SE
alleles, supporting the view that genes with a
moderate risk can exert a stronger effect in
combination with other risk loci.9
Recently, selenoprotein S (SELS) has been
identified as an important regulator of IL1, TNF
and IL6 production with plasma levels of these
proteins correlating with functional promoter
single nucleotide polymorphisms (SNPs) in
SELS.10 This gene is involved in the stress response
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within the endoplasmic reticulum (ER) and inflammation. We
hypothesised that variants in SELS could influence RA suscept-
ibility and may interact with functional SNPs in the genes for
IL1, IL6 and TNF that have been previously associated with RA.
METHODS
Study populations
A total of 988 Caucasians (healthy unrelated individuals) and
965 individuals with RA participated in this study and have
been described previously.11 All patients fulfilled the American
College of Rheumatology (ACR) criteria and had a minimum
disease duration of 3 years. The South Sheffield Research Ethics
Committee approved this study and informed consent was
obtained from all participants.
SNP genotyping
Blood samples were collected in EDTA anticoagulated tubes and
DNA was extracted using standard methods. TaqMan genotyp-
ing assays were designed for functional SNPs in IL1b, IL6, TNF
and SELS as previously described (table 1).12 Thermal cycling
was performed as follows; after an initial denaturation and
enzyme activation of 10 min at 95uC, samples were subjected to
40 cycles of 15s at 95uC for denaturation and 60s at 60uC for
annealing/extension. We included multiple positive and nega-
tive controls in all genotyping plates and repeated 10% of our
samples to minimise genotyping errors. Thermal cycling in 384-
well plates was performed on a PTC-225 DNA engine Tetrad
(MJ Research, San Francisco, California, USA) and genotypes
were determined using an ABI Prism 7900HT (PE Biosystems,
Foster City, California, USA).
Statistical analysis
Deviation from Hardy–Weinberg equilibrium (HWE) was tested
for each SNP in cases and controls separately using a x2 test
with a threshold of p,0.05. The odds ratios (ORs) were
calculated with asymptotic 95% confidence intervals (CIs). The
mode of inheritance at each locus was determined by the ORs
for RA in the three genotype groups.
Gene–gene interactions are often measured as departure
from an additive or multiplicative genetic model by, for
example, adding a product term between two risk factors in a
logistic regression model (statistical interaction), however this
method which treats interaction as a residual term in a
regression model has no clear biological interpretation. To
study gene–gene interactions in addition to the Mantel–
Haenszel (M–H) test we have used a recently described test for
interactions between two unlinked loci. This model is based
on the assumption that two interacting loci will create linkage
disequilibrium (LD) even if these loci are unlinked, the level of
which depends on the extent of the interaction. This
definition describes the dependence of penetrance for a two-
loci haplotype where the penetrance of one locus depends on
the genotypes at another locus.13 The LD-based statistic
provides a clearer biological interpretation of epistasis and
also an increased power to detect gene–gene interactions under
several plausible models of interactions.
Therefore we first stratified study subjects according to IL1
genotypes. Differences in odds ratios of RA (comparing two
SELS genotype groups) in the different IL1 genotype groups
were determined using the M–H test. In each pairwise test of
statistical interaction, the mode of inheritance considered at
each locus was that used for the main effects. An alternative
method based on measuring the departure from independence
of penetrances in two unlinked loci (an LD-based statistic) was
also performed. A total of 7 tests for main effects and 21 tests
for gene–gene interactions were performed (total of 28 tests).
Applying a Bonferroni correction to this number of tests
would require a p value less than 0.002 to ensure a
conventional type 1 error rate of 5%. The Bonferroni
correction however assumes independent tests and is con-
servative for correlated tests, as the tests in this study are. All
p values given in the text are unadjusted and should be judged
against the adjusted cut-off of 0.002, bearing in mind that it is
a conservative threshold. All statistical analyses were carried
out using STATA statistical software (V 9.1, STATA, College
Station, Texas, USA).
RESULTS
Genotype and allele distributions
Baseline characteristics of the study populations are summarised
elsewhere.12 Allele and genotype frequencies for all SNPs were in
HWE for RA cases and controls. Table 2 shows the genotype
frequencies of each SNP in healthy controls and RA cases. A
marginal association was detected between IL1b 2511 and RA
susceptibility. The 2511AA genotype was under-represented in
RA cases compared to healthy controls (OR 0.7, 95% CI 0.5 to
1.0, p = 0.04). Genotypes frequencies were not significantly
different for any other variant.
Interaction between IL1b 2511 and SELS 2105
The genotype frequencies for different combinations of IL1b
2511 and SELS 2105 for RA cases and controls are shown in
table 3. The presence of a significant interaction was detected
using a stratified analysis (M–H test). The OR comparing
individuals with the AA/GA genotype to the GG genotype at
the SELS 2105 locus in participants who were GG/AG at the
IL1b 2511 locus was 0.9 (95% CI 0.7 to 1.1, p = 0.3). In
contrast, the presence of at least one copy of the A allele at the
SELS 2105 locus (compared to no copies) was associated with
an increased risk of RA in subjects who were AA at the IL1b
2511 locus (OR 2.3, 95% CI 1.2 to 4.5, p = 0.007) (table 2).
Applying a M–H test of homogeneity of odds ratios suggests
that the risk of RA to carriers of the AA/GA genotype compared
to the GG genotype at the SELS 2105 locus depends upon their
genotype at the IL1b 2511 locus (p = 0.004). While this falls
just short of the Bonferroni threshold it is clearly suggestive of a
statistical interaction. The LD test statistic yielded stronger,
highly significant evidence of a gene–gene interaction between
the SELS 2105 and IL1b 2511 loci (p =,0.001). This
considerably exceeds the Bonferroni threshold and together
with the M–H analysis provides compelling evidence for a
statistical interaction between the SELS 2105 and IL1b 2511
loci in RA. No interaction was detected between SELS2105 and
Table 1 Details of individual single nucleotide polymorphisms (SNPs)
dbSNPID Gene Description
rs17561 IL1A Ser114Ala
rs16944 IL1b Promoter (2511)
rs1143634 IL1b Synonymous coding, Phe105Phe
rs1800795 IL6 Promoter (2174)
rs28665122 SELS 59 UTR (2105)
rs4965814 SELS Intron 5 (+3705)
rs4965373 SELS 39 UTR (+5227)
The dbSNPID accession number (http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp)
and details of location and functional effects of variant are given.
UTR, untranslated region.
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the other cytokine SNPs (p = 0.6 for IL62174; p = 0.2 for
IL1+3954; p = 0.2; for IL1+4845; p = 0.9; p = 0.6 for TNF308 by
M–H test).
Subjects were stratified according to the IL1b 2511 genotype
and odds ratios for the SELS 2105 gene were calculated in both
strata separately. The genetic models used were those pre-
viously assigned to each polymorphism and the M–H test was
used.
DISCUSSION
In this study we report strong statistical evidence of an
interaction between two functional polymorphisms in the
IL1b and SELS genes with increased risk of developing RA.
There is a large body of evidence implicating IL1 in RA; it is
found at high levels in serum and synovial fluid of patients with
RA and evidence has shown that, together with TNFa, it
upregulates the expression of matrix metalloproteinases
(MMPs) and cell adhesion molecules (CAMs) that are important
in bone cartilage and bone resorption.14 Deletion of the IL1
receptor antagonist gene in Balb/C mice results in an
inflammatory polyarthritis.15 A number of polymorphisms in
the IL1 cluster have been extensively associated with inflam-
matory conditions. The IL1b 2511 polymorphism has been
shown to result in loss of a putative activating protein 2 (AP-2)
binding site, suggesting its functional importance.16
Furthermore a haplotype consisting of 2511T and the 231C
has been associated with a twofold to threefold increase in LPS-
induced IL1b protein production.16 The SELS 2105 variant is
located within a putative endoplasmic reticulum (ER) stress
response element (ERSE) and the A allele is associated with
impaired SELS expression, leading to increased production of
proinflammatory mediators.10
SELS is a gene involved in ER stress response. It encodes a
membrane protein that removes misfolded proteins from the ER
to the cytosol and prevents stress responses that lead to
activation of the inflammatory cascade.10 Genetic variation of
SELS has been associated with circulating levels of the
proinflammatory cytokines IL1b, IL6 and TNF. The promoter
variant (2105G.A) significantly impairs SELS expression
resulting in increased cytokine production and differential ER
stress response, suggesting it to be a strong candidate in the
pathogenesis of common inflammatory diseases.10 However we
did not detect a significant association of SELS promoter
variants with susceptibility to RA.
As genetic variation of SELS influences circulating levels of
proinflammatory cytokines, the presence of epistasis with
functional cytokine variants was investigated. Using stratification
and LD-based methods significant interaction was observed
between the IL1b 2511 and SELS 2105 loci, with the latter
method detecting much stronger evidence of epistasis. This may
be due to the greater statistical power of the LD-based test
statistic compared to the M–H test statistic. The LD-based
statistic has been shown to have greater power than logistic
regression under several plausible models of epistasis and so it is
reasonable to expect that it would also have greater power than
the M–H test statistic. Of course other functional genetic variants
in high LD with either SNP may be the causative polymorphisms
that contribute to increased disease susceptibility. Our data
clearly demonstrate that these two genes interactively increase
the risk of developing RA. Given the observation of Curran et al
and the role of IL1 in RA the increased frequency of the 2105A
and 2511A alleles is expected in RA cases and is in line with
previous findings.
Our data suggest that the A allele at the SELS 2105 locus is a
new candidate for RA pathogenesis in individuals who are
homozygous for the rare allele at the IL1b 2511 locus. Although
our results are based on small numbers, they confirm the
importance of epistatic interactions in the pathogenesis of
complex diseases and support the hypothesis that polymorph-
isms in genes with either moderate or no main effects can have
Table 2 Genotype frequencies and disease status
Gene Genotype Cases n (%) Controls n (%) OR (95% CI) p Value
IL1 2511 AA 90 (9.6%) 117 (12.5%) 0.7 (0.5 to 1.0) 0.04
GA/GG 852 (90.4%) 820 (87.5%) 1.0
IL1 +3954 TT 40 (4.5%) 49 (5.5%) 0.8 (0.5 to 1.3) 0.3
TC/CC 850 (95.5%) 842 (94.5%) 1.0
IL6 2174 CC/CG 656 (69.9%) 621 1.2 (1.0 to 1.4) 0.1
GG 282 (30.1%) 314 1.0
TNF 2308 AA 19 (4.1%) 24 (5.4%) 0.7 (0.4 to 1.4) 0.4
GG/AG 442 (95.6%) 418 (94.6%) 1.0
SELS 2105 AA/GA 235 (26.7%) 250 (26.6%) 1.0 (0.8 to 1.2) 0.9
GG 644 (73.3%) 690 (73.4%) 1.0
SELS +3705 TT 24 (2.5%) 28 (2.9%) 0.9 (0.5 to 1.6) 0.6
TC/CC 920 (97.5%) 936 (97.1%) 1.0
SELS +5227 GG/GA 504 (56.2%) 490 (55.4%) 1.1 (0.9 to 1.3) 0.3
AA 393 (43.8%) 395 (44.6%) 1.0
OR, odds ratio.
Table 3 Stratification analysis according to IL1 and SELS genotypes
SELS 2105
IL1b 2511
GA/GG AA
RA Controls OR (95% CI) p Value RA Controls OR (95% CI) p Value
AA/GA 191 214 0.9 (0.7 to 1.1) 0.3 35 26 2.3 (1.2 to 4.5) 0.007
GG 579 571 1.0 – 47 81 1.0 –
Mantel–Haenszel test of homogeneity, p value 0.004.
IL, interleukin; OR, odds ratio; RA, rheumatoid arthritis; SELS, selenoprotein S.
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significant effects when combined with polymorphisms at other
susceptibility loci.
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